ALDX
Price
$4.27
Change
-$0.14 (-3.17%)
Updated
Nov 14 closing price
111 days until earnings call
PHAT
Price
$9.09
Change
-$0.66 (-6.77%)
Updated
Nov 14 closing price
109 days until earnings call
Ad is loading...

ALDX vs PHAT

Header iconALDX vs PHAT Comparison
Open Charts ALDX vs PHATBanner chart's image
Aldeyra Therapeutics
Price$4.27
Change-$0.14 (-3.17%)
Volume$686.82K
CapitalizationN/A
Phathom Pharmaceuticals
Price$9.09
Change-$0.66 (-6.77%)
Volume$1.48M
CapitalizationN/A
ALDX vs PHAT Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALDX vs. PHAT commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and PHAT is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ALDX: $4.27 vs. PHAT: $9.09)
Brand notoriety: ALDX and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 155% vs. PHAT: 106%
Market capitalization -- ALDX: $254.28M vs. PHAT: $621.55M
ALDX [@Biotechnology] is valued at $254.28M. PHAT’s [@Biotechnology] market capitalization is $621.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • PHAT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -20.04% price change this week, while PHAT (@Biotechnology) price change was -50.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 06, 2025.

PHAT is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($622M) has a higher market cap than ALDX($254M). ALDX YTD gains are higher at: 21.652 vs. PHAT (-0.438).
ALDXPHATALDX / PHAT
Capitalization254M622M41%
EBITDAN/AN/A-
Gain YTD21.652-0.438-4,942%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ALDX: Fundamental Ratings
ALDX
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALDXPHAT
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
0%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-3.17%
GSGTF - ALDX
56%
Loosely correlated
N/A
QSI - ALDX
47%
Loosely correlated
-1.52%
BBIO - ALDX
44%
Loosely correlated
-2.74%
FOLD - ALDX
44%
Loosely correlated
-2.70%
CRNX - ALDX
44%
Loosely correlated
+1.26%
More

PHAT and

Correlation & Price change

A.I.dvisor tells us that PHAT and ALDX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHAT and ALDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-6.77%
ALDX - PHAT
31%
Poorly correlated
-3.17%
TSHA - PHAT
30%
Poorly correlated
+2.71%
SNDX - PHAT
29%
Poorly correlated
+0.96%
OTLK - PHAT
29%
Poorly correlated
-7.55%
ABOS - PHAT
28%
Poorly correlated
+3.16%
More